Table 4

Comparisons for patients with dependency in ADL 6 months after EC


ADL Dependency

Variable
No (n = 15)
Yes (n = 28)
P

Age, median
67
70
0.365b
Gender, n(%)


0.231a
     Female
2 (13)
8 (29)

     Male
13 (87)
20 (71)

BMI, median
25.7
25.7
0.908b
Duration of anesthesia (min.), median
150
180
0.057a
T ype of anesthesia, n(%)


0.239a
     General
4 (27)
12 (43)

     Local
11 (73)
16 (57)

High-risk patients, n (%)
2 (13)
6 (21)
0.417a
Temperature at admission
35.6
36.0
0.474b
Troponin I at admission
0.001
0.002
0.178b
Hypertension, n(%)
14 (93)
27 (96)
0.581a
Hyperlipidemia, n(%)
12 (80)
24 (86)
0.468a
Ischemic heart disease, n(%)
7 (47)
21 (75)
0.065a
Congestive heart disease
0
3 (11)
0.265a
Cerebrovascular disease
5 (33)
14 (50)
0.235a
Insulin therapy for diabetes
1 (7)
0
0.349a
Preoperative serum creatinine > 2 mg/dl
0
1 (4)
0.651a
RCRI score, median
1.0
1.5
0.017b
SAPS II, median
15.0
17.0
0.239b
APACHE II, median
7.0
7.0
0.301b
Length of PACU stay (hours), median
19.0
20.0
0.768b
Length of Hospital stay (days), median
5.0
5.0
0.326b

a Pearson χ2. b Mann-Whitney test.

There were no significant differences after controlling for multiple comparisons

BMI, Body mass index; RCRI, Revised Cardiac Risk Index; SAPS II, Simplified Acute Physiology Score; APACHE II, Acute Physiology and Chronic Health Evaluation; PACU, Post Anesthesia Care Unit;

Abelha et al. BMC Cardiovascular Disorders 2008 8:33   doi:10.1186/1471-2261-8-33